Skip to content

Study · Not a test of the peptide alone · 1995

1 result

Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.

Oldziej S, Ciarkowski J, Liwo A, Shenderovich MD, Grzonka Z

Journal of receptor and signal transduction research1 Jan 1995Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01Computer modelNot a test of Oxytocin aloneIn silicoMechanism

    In conformational calculations, the oxytocin-selective antagonist penicilide probably mimics the Tyr2 residue and the Ile3 or Leu8 residues of oxytocin, which links to its affinity and selectivity.

    In plain wordsIn computer models, a drug that blocks the oxytocin receptor probably copies parts of the oxytocin shape.

    Peptide
    Oxytocin
    Outcome
    Not applicableMimicry of oxytocin residues by a non-peptide antagonist
    Study

    n: not reported in source

    Conformational energy calculations
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    with mimicking the Tyr2 residue and the Ile3 or Leu8 residues of OT by the outer benzene ring and the isobutyl group of compound 1.
    1 context sentence
    Summary · context
    The obtained low-energy conformations of compound 1 were compared with low-energy conformations of oxytocin (OT)

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.